Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease

In order to assess peripheral levels and activities of a broad spectrum of non-enzymatic and enzymatic antioxidants in elderly subjects with mild cognitive impairment (MCI) and Alzheimer's disease (AD), plasma levels of water-soluble (Vitamin C and uric acid) and of lipophilic (Vitamin A, Vitamin E and carotenoids including lutein, zeaxanthin, beta-cryptoxanthin, lycopene, alpha- and beta-carotene) antioxidant micronutrients as well as activities of plasma and red blood cell (RBC) superoxide dismutase (SOD) and of plasma glutathione peroxidase (GPx) were measured in 25 patients with MCI, 63 AD patients and 53 controls. Peripheral levels and activities of antioxidants were similarly lower in MCI and AD patients as compared to controls. As MCI may represent a prodromal stage of AD, and oxidative damage appears to occur as one of the earliest pathophysiological events in AD, an increased intake of antioxidants in patients with MCI could be helpful in lowering the risk of conversion to dementia.

[1]  M. Beal,et al.  Aging, energy, and oxidative stress in neurodegenerative diseases , 1995, Annals of neurology.

[2]  J. Price,et al.  Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.

[3]  J. Morris,et al.  Current concepts in mild cognitive impairment. , 2001, Archives of neurology.

[4]  W. Stahl,et al.  Carotenoid mixtures protect multilamellar liposomes against oxidative damage: synergistic effects of lycopene and lutein , 1998, FEBS letters.

[5]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[6]  R. Lévy,et al.  Aging-Associated Cognitive Decline , 1994, International Psychogeriatrics.

[7]  G. Perry,et al.  Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. , 2000, Antioxidants & redox signaling.

[8]  Y. Christen,et al.  Oxidative stress and Alzheimer disease. , 2000, The American journal of clinical nutrition.

[9]  D. Butterfield,et al.  Vitamin Ε as an Antioxidant/Free Radical Scavenger Against Amyloid β-Peptide-Induced Oxidative Stress in Neocortical Synaptosomal Membranes and Hippocampal Neurons in Culture: Insights into Alzheimer's Disease , 1999 .

[10]  R. Carrell,et al.  The estimation of red cell superoxide dismutase activity. , 1975, The Journal of laboratory and clinical medicine.

[11]  Xudong Huang,et al.  Metal Chelation as a Potential Therapy for Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[12]  C. Bell.  DSM-IV: Diagnostic and Statistical Manual of Mental Disorders , 1994 .

[13]  D. Nierenberg,et al.  A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. , 1992, The American journal of clinical nutrition.

[14]  R. Ortega,et al.  Cognitive function in elderly people is influenced by vitamin E status. , 2002, The Journal of nutrition.

[15]  M. Polidori,et al.  Profiles of antioxidants in human plasma. , 2001, Free radical biology & medicine.

[16]  P. Greengard,et al.  Intraneuronal Aβ42 Accumulation in Human Brain , 2000 .

[17]  Patrizia Mecocci,et al.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.

[18]  M. Meydani,et al.  Antioxidants and cognitive function. , 2009, Nutrition reviews.

[19]  J. Morrow,et al.  Antioxidant Activity of Vitamin C in Iron-overloaded Human Plasma* , 1997, The Journal of Biological Chemistry.

[20]  M. Catani,et al.  Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. , 2002, Archives of neurology.

[21]  S. Omaye,et al.  An internal standard method for the unattended high-performance liquid chromatographic analysis of ascorbic acid in blood components. , 1987, Analytical biochemistry.

[22]  A. Stocker,et al.  Vitamin E: non-antioxidant roles. , 2000, Progress in lipid research.

[23]  M. Ganguli,et al.  Use of antioxidant supplements and its association with cognitive function in a rural elderly cohort: the MoVIES Project. Monongahela Valley Independent Elders Survey. , 1998, American journal of epidemiology.

[24]  Douglas R. McDonald,et al.  Amyloid Fibrils Activate Tyrosine Kinase-Dependent Signaling and Superoxide Production in Microglia , 1997, The Journal of Neuroscience.

[25]  B. Ames,et al.  Ascorbate is an outstanding antioxidant in human blood plasma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Flohé,et al.  Assays of glutathione peroxidase. , 1984, Methods in enzymology.

[27]  P. Mecocci,et al.  Oxidative damage to DNA in lymphocytes from AD patients , 1998, Neurology.

[28]  G. Perry,et al.  The role of metals in neurodegenerative diseases. , 2000, Cellular and molecular biology.

[29]  B. Vellas,et al.  Low plasma vitamin C in Alzheimer patients despite an adequate diet , 1998, International journal of geriatric psychiatry.

[30]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[31]  W. Stahl,et al.  Separation of beta-carotene and lycopene geometrical isomers in biological samples. , 1993, Clinical chemistry.

[32]  B. H. Choi.  Oxidative stress and Alzheimer's disease , 1995, Neurobiology of Aging.

[33]  I. Bourdel-Marchasson,et al.  Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. , 2001, Age and ageing.

[34]  W. Markesbery,et al.  Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.

[35]  Virginia M. Y. Lee,et al.  Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis , 2001, The Journal of Neuroscience.

[36]  A. Hofman,et al.  Dietary Intake of Antioxidants and Risk of Alzheimer Disease , 2002 .

[37]  R. Chandra.  Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. , 2001, Nutrition.

[38]  A. Alpérovitch,et al.  Cognitive Decline Is Associated with Systemic Oxidative Stress: The EVA Study , 2000, Journal of the American Geriatrics Society.

[39]  A. Nunomura,et al.  Oxidative Damage Is the Earliest Event in Alzheimer Disease , 2001, Journal of neuropathology and experimental neurology.

[40]  R. Schmidt,et al.  Plasma Antioxidants and Cognitive Performance in Middle‐Aged and Older Adults: Results of the Austrian Stroke Prevention Study , 1998, Journal of the American Geriatrics Society.

[41]  J. Trojanowski,et al.  Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. , 2002, Archives of neurology.

[42]  M. L’Abbé,et al.  [21] Automated assay of superoxide dismutase in blood , 1990 .

[43]  D. T. Vernier,et al.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.